Who owns ADICET BIO ORD?
- Ticker: ACET
- CUSIP Number: 007002207
Tip: Access positions for across all investors
Analyze quarterly positions in Adicet Bio Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adicet Bio Ord stock
Who bought or sold ADICET BIO ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 1.2M | $8.1M | 25% | Mar 2026 |
|
| OrbiMed Advisors | 1.0M | $7.0M | 0% | Mar 2026 |
|
| Franklin Resources | 627k | $4.3M | 0% | Mar 2026 |
|
| Citadel Advisors | 382k | $2.6M | 254% | Mar 2026 |
|
| Vanguard Capital Management | 337k | $2.3M | 100% | Mar 2026 |
|
| Woodline Partners | 313k | $2.1M | -50% | Mar 2026 |
|
| Vanguard Group | 291k | $2.5M | 100% | Dec 2025 |
|
| Adage Capital Partners GP | 274k | $2.3M | 100% | Dec 2025 |
|
| Prosight Management | 250k | $2.1M | 100% | Dec 2025 |
|
| Renaissance Technologies | 243k | $2.0M | 100% | Dec 2025 |
|
| Stonepine Capital Management | 220k | $1.9M | 100% | Dec 2025 |
|
| Alyeska Investment Group | 204k | $1.4M | 0% | Mar 2026 |
|
| Carlyle | 184k | $1.3M | 0% | Mar 2026 |
|
| Acadian Asset Management | 118k | $802k | -35% | Mar 2026 |
|
| Geode Capital Management | 101k | $689k | 14% | Mar 2026 |
|
| DAFNA Capital Management | 94k | $639k | 0% | Mar 2026 |
|
| Burkehill Global Management | 63k | $426k | 0% | Mar 2026 |
|
| Bridgeway Capital Management | 56k | $475k | 100% | Dec 2025 |
|
| Rangeley Capital | 56k | $381k | 124% | Mar 2026 |
|
| ADAR1 Capital Management | 54k | $367k | -58% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 50k | $343k | 100% | Mar 2026 |
|
| Trexquant Investment | 44k | $297k | 100% | Mar 2026 |
|
| Two Sigma Investments | 43k | $294k | -70% | Mar 2026 |
|
| Rbf Capital | 39k | $263k | 0% | Mar 2026 |
|
| UBS Group | 38k | $261k | 910% | Mar 2026 |
|
| Jane Street | 37k | $253k | 100% | Mar 2026 |
|
| BlackRock | 37k | $249k | 0% | Mar 2026 |
|
| Maven Securities | 31k | $263k | 100% | Dec 2025 |
|
| State Street Corporation | 26k | $218k | 100% | Dec 2025 |
|
| Barclays | 25k | $211k | 100% | Dec 2025 |
|
| Johnson & Johnson | 23k | $155k | 0% | Mar 2026 |
|
| XTX Topco | 19k | $157k | 100% | Dec 2025 |
|
| Occudo Quantitative Strategies | 15k | $114k | 100% | Mar 2026 |
|
| Vontobel Holding | 14k | $97k | 100% | Mar 2026 |
|
| Northern Trust | 14k | $118k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 11k | $73k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 5.2k | $36k | 100% | Mar 2026 |
|
| Goss Wealth Management | 3.9k | $26k | 100% | Mar 2026 |
|
| Morgan Stanley | 3.5k | $24k | 15% | Mar 2026 |
|
| FNY Investment Advisers | 3.2k | $21k | -48% | Mar 2026 |
|
| Royal Bank of Canada | 1.7k | $11k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.1k | $9.0k | 100% | Dec 2025 |
|
| Efficient Wealth Management | 246.00 | $999.990000 | 100% | Mar 2026 |
|
| Simplex Trading | 87.00 | $732.000600 | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 50.00 | $340.000000 | 0% | Mar 2026 |
|
| FMR | 34.00 | $286.001200 | 100% | Dec 2025 |
|
| SBI Securities | 19.00 | $129.000500 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $20.000100 | 100% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $7.000000 | 0% | Mar 2026 |
|
Who sold out of Adicet Bio Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Dec 2025 | 235k | $2.0M |
| Two Sigma Advisers | Dec 2025 | 111k | $937k |
| Luminus Management | Dec 2025 | 60k | $502k |
| Squarepoint Ops | Dec 2025 | 56k | $469k |
| GSA Capital Partners | Dec 2025 | 18k | $150k |
| Tang Capital Management | Dec 2025 | 6.2k | $52k |
| Hollencrest Securities | Dec 2025 | 250.00 | $2.1k |